RETINAI OCT NAVIGATOR
LIVE

Serial Number

79449768

Owner

Ikerian AG

Filing Date

Feb 27, 2026

Add to watchlist:

No watchlists yet
View on USPTO

RETINAI OCT NAVIGATOR Trademark

Serial Number: 79449768

RETINAI OCT NAVIGATOR is a trademark filed by Ikerian AG on February 27, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Ikerian AG (7 trademarks)

Freiburgstrasse 3

Entity Type: 25

Trademark Details

Filing Date

February 27, 2026

Registration Date

Not Registered

Goods & Services

Application software; embedded operating software; computer hardware and software; computer software for data and document capture, transmission, storage and indexing; computer software platforms; Software as a Medical Device (SaMD).

Computer software development; Platform as a Service (PaaS); Software as a Service (SaaS); design and development of computer hardware and software for medical use; research in the field of artificial intelligence; biomedical research; medical research; scientific research for medical purposes; providing information and data with respect to scientific and technological research and development; scientific and technological services as well as research and development services relating thereto; industrial analysis and industrial research services; data migration services; providing information and data with respect to medical and veterinary research and development.

Remote monitoring of medical data for medical diagnosis and treatment purposes; medical advice; medical examinations; medical information; medical testing services relating to disease diagnosis and treatment; medical information services provided via the Internet; medical testing for the diagnosis and treatment of persons; medical diagnostic services (testing and analysis); provision of medical information; medical services in the field of ophthalmology, including eye diseases and oculomics (namely autoimmune diseases (Graves’ disease, multiple sclerosis (MS)), chronic kidney disease, vascular diseases (diabetes, heart disease, high risk of stroke and hypertension), hereditary diseases (Stargardt disease and retinitis pigmentosa) and neurodegenerative diseases (Alzheimer’s disease and Parkinson’s disease)), in particular vision assessment. treatment of vision disorders; professional consultancy in the field of medical technology, medical surgery and orthopedics.

Filing History

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 18, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jun 17, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 15, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
May 8, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 8, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 7, 2026 REPR